Spontaneous pneumothorax and subcutaneous emphysema in COVID-19 patient: Case report

Üçpınar, Burçin Ağrıdağ; Şahin, Cennet; Yanç, Uğur

doi:10.1016/j.jiph.2020.05.012

Cited by 90 publications

(93 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Subsequent case reports described COVID-19-associated pneumothorax with or without subcutaneous emphysema on the first day of diagnosis. [9][10][11] Our case series support the probability that pneumothorax happens in the setting of COVID-19 pneumonia resulting from advanced alveolar damage, and the bronchiolar distortion and narrowing caused by SARS-CoV-2 leading to pulmonary bullae formation. Moreover, the severe cough associated with viral infections increases the intrapulmonary pressure.…”

Section: Discussionsupporting

confidence: 60%

Case Report: COVID-19–Related Pneumothorax—Case Series Highlighting a Significant Complication

Al-Shokri

Ahmed

Saleh

et al. 2020

The American Journal of Tropical Medicine and Hygiene

View full text Add to dashboard Cite

COVID-19 is a recent outbreak in China and rapidly spread worldwide. Lung consolidation is the most common radiologic finding of COVID-19 pneumonia. Pneumothorax has been rarely reported as a complication of severe COVID-19 pneumonia. Early recognition and management are detrimental to the outcome. We here report three cases of SARS-CoV-2 infection complicated by pneumothorax. In addition, we present a brief literature review.

show abstract

Section: Discussionsupporting

confidence: 60%

Case Report: COVID-19–Related Pneumothorax—Case Series Highlighting a Significant Complication

Al-Shokri

Ahmed

Saleh

et al. 2020

The American Journal of Tropical Medicine and Hygiene

View full text Add to dashboard Cite

show abstract

“…First, we had three pneumothorax cases in addition to one case of pneumomediastinum and subcutaneous emphysema among only 22 severe COVID-19 cases. There have so far been some case reports, all of which describe they are rare complications [33][34][35][36]; however, from this study it is unlikely that we can say they are rare. All cases demonstrating pneumothorax were treated by thoracostomy with trocar insertion and continuous low negative pressure.…”

Section: Treatments and Clinical Outcomesmentioning

confidence: 65%

Characteristics, laboratories, and prognosis of severe COVID-19 in the Tokyo metropolitan area: A retrospective case series

Mori

Otomo

2020

PLoS ONE

View full text Add to dashboard Cite

The impact of the COVID-19 pandemic has been immense, while the epidemiology and pathophysiology remain unclear. Despite many casualties in many countries, there have been less than 1,000 deaths in Japan as of end of June, 2020. In this study, we analyzed the cases of COVID-19 patients admitted to our institution located in the Tokyo metropolitan area where the survival rate is higher than those in other cities in the world. Medical records of COVID-19 patients that were admitted to a single Japanese tertiary university hospital in the Tokyo metropolitan area between March 10th and June 2nd, 2020 were retrospectively reviewed. The identified COVID-19 cases were subdivided into two groups (severe and mild) depending on the need for mechanical ventilation. Those in the severe group required mechanical ventilation as opposed to those in the mild group. The data were analyzed using nonparametric tests expressed by median [interquartile range (IQR)]. A total of 45 COVID-19 patients were included, consisting of 22 severe cases (Group S) and 23 mild cases (Group M). Male sex (Group S, 95.5% vs. Group M, 56.5%, p<0.01), high body mass index (Group S, 24.89 [22.44-27.15] vs. Group M, 21.43 [19.05-23.75], p<0.01), and hyperlipidemia (Group S, 36.4% vs. Group M, 0%, p<0.01) were more seen in Group S. Five (22.7%) cases in Group S underwent extracorporeal membranous oxygenation (ECMO). On admission, lymphopenia, decreased albumin, and elevated fibrinogen, lactate dehydrogenase, transaminases, creatine kinase, C-reactive protein, and procalcitonin were observed in Group S. The median ICU and hospital stay were 13.5 [10.3-22.3] days and 23.0 [16.3-30.5] days, respectively, in Group S. As of June 28th, 2020, in Group S, 19 (86.4%) patients have survived, of which 17 (77.3%) were discharged, and 2 are still in treatments. Three died of multiple organ failure. All 23 patients in Group M have recovered. Male sex, high body mass index, and hyperlipidemia can be risk factors for severe COVID-19 pneumonia, and its overall short-term survival rate was between 77.3% and 86.4% in this study.

show abstract

“…Pneumothorax has been reported as a complication of COVID-19 pneumonia and sometimes as a presenting feature reported by other case reports [3][4][5][6][7][8][9].…”

Section: Discussionmentioning

confidence: 96%

Bilateral Hemopneumothorax in COVID-19

Salah¹,

Faisal²,

Alshahwani³

et al. 2020

Cureus

View full text Add to dashboard Cite

A 50-year-old previously healthy male presented with fever and cough for seven days, positive for COVID-19, and was admitted to Hazm Meberik General Hospital and treated as a case of severe COVID-19 pneumonia. After improvement, he was transferred to a quarantine facility, and he later developed bilateral hemopneumothorax requiring bilateral chest tubes. Highresolution CT showed bilateral emphysematous bullous disease. Tuberculosis workup was negative, and alpha 1 anti-trypsin levels were normal. Repeated Chest X-ray showed improvement and chest tubes were removed. The patient was discharged with follow-up with the thoracic surgery clinic.

show abstract

Spontaneous pneumothorax and subcutaneous emphysema in COVID-19 patient: Case report

Cited by 90 publications

References 9 publications

Case Report: COVID-19–Related Pneumothorax—Case Series Highlighting a Significant Complication

Case Report: COVID-19–Related Pneumothorax—Case Series Highlighting a Significant Complication

Characteristics, laboratories, and prognosis of severe COVID-19 in the Tokyo metropolitan area: A retrospective case series

Bilateral Hemopneumothorax in COVID-19

Contact Info

Product

Resources

About